J. William Owens
Procter & Gamble
Cincinnati
Ohio 45253-8707
USA
Name/email consistency: high
- The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose-response studies. Owens, W., Gray, L.E., Zeiger, E., Walker, M., Yamasaki, K., Ashby, J., Jacob, E. Environ. Health Perspect. (2007)
- The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses. Phase 1: use of a potent agonist and a potent antagonist to test the standardized protocol. Owens, W., Zeiger, E., Walker, M., Ashby, J., Onyon, L., Gray, L.E. Environ. Health Perspect. (2006)
- Weighing the results of differing 'low dose' studies of the mouse prostate by Nagel, Cagen, and Ashby: quantification of experimental power and statistical results. Owens, J.W., Chaney, J.G. Regul. Toxicol. Pharmacol. (2005)
- The OECD program to validate the rat uterotrophic bioassay: an overview. Owens, W., Koëter, H.B. Environ. Health Perspect. (2003)
- The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses. Owens, W., Ashby, J., Odum, J., Onyon, L. Environ. Health Perspect. (2003)
- Chemical toxicity indicators for human health: case study for classification of chronic noncancer chemical hazards in life-cycle assessment. Owens, J.W. Environ. Toxicol. Chem. (2002)
- Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Owens, J.W., Ashby, J. Crit. Rev. Toxicol. (2002)
